Next Article in Journal
P-Glycoprotein (ABCB1/MDR1) and BCRP (ABCG2) Limit Brain Accumulation and Cytochrome P450-3A (CYP3A) Restricts Oral Exposure of the RET Inhibitor Selpercatinib (RETEVMO)
Next Article in Special Issue
Diversity-Oriented Synthesis: Amino Acetophenones as Building Blocks for the Synthesis of Natural Product Analogs
Previous Article in Journal
Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
Previous Article in Special Issue
Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition
Article

Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A

1
Institut des Sciences Chimiques de Rennes ISCR UMR CNRS 6226, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France
2
S2Wave Platform, ScanMAT UMS 2001 CNRS, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France
3
ImPACcell Platform, SFR Biosit, Université de Rennes 1, Bât. 8, Campus Villejean, 2 Avenue du Prof. Léon Bernard, CS 34317, CEDEX, 35043 Rennes, France
4
Institut de Recherche en Santé, Environnement et Travail, IRSET Inserm U1085, Université de Rennes 1, 9 Avenue du Prof. Léon Bernard, 35000 Rennes, France
5
Laboratoire de Synthèse et de Catalyse, Université Ibn Khaldoun, Tiaret 14000, Algeria
6
Perha Pharmaceuticals & ManRos Therapeutics, “From Sea to Pharmacy”, Hôtel de Recherche, 29680 Roscoff, France
7
Protein Phosphorylation & Human Disease Group, Station Biologique, 29680 Roscoff, France
*
Author to whom correspondence should be addressed.
Academic Editor: Daniela Catarzi
Pharmaceuticals 2021, 14(11), 1086; https://doi.org/10.3390/ph14111086
Received: 5 July 2021 / Revised: 21 October 2021 / Accepted: 22 October 2021 / Published: 27 October 2021
(This article belongs to the Special Issue Heterocyclic Compounds and Their Application in Therapy)
Here, we report on the synthesis of libraries of new 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones 3 (twenty-two compounds) and new 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones 5 (twenty-four compounds) with stereo controlled Z-geometry under microwave irradiation. The 46 designed final compounds were tested in order to determine their activity against four representative protein kinases (DYR1A, CK1, CDK5/p25, and GSK3α/β). Among these 1,3-thiazolidin-4-ones, the molecules (5Z) 5-(4-hydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one 3e (IC50 0.028 μM) and (5Z)-5-benzo[1,3]dioxol-5-ylmethylene-2-(pyridin-2-yl)amino-1,3-thiazol-4(5H)-one 5s (IC50 0.033 μM) were identified as lead compounds and as new nanomolar DYRK1A inhibitors. Some of these compounds in the two libraries have been also evaluated for their in vitro inhibition of cell proliferation (Huh7 D12, Caco2, MDA-MB 231, HCT 116, PC3, and NCI-H2 tumor cell lines). These results will enable us to use the 1,3-thiazolidin-4-one core as pharmacophores to develop potent treatment for neurological or oncological disorders in which DYRK1A is fully involved. View Full-Text
Keywords: microwave; Knoevenagel condensation; sulphur/nitrogen displacement; 1,3-thiazolidin-4-one; inhibition; protein kinase; DYRK1A; cell lines microwave; Knoevenagel condensation; sulphur/nitrogen displacement; 1,3-thiazolidin-4-one; inhibition; protein kinase; DYRK1A; cell lines
Show Figures

Figure 1

MDPI and ACS Style

Bourahla, K.; Guihéneuf, S.; Limanton, E.; Paquin, L.; Le Guével, R.; Charlier, T.; Rahmouni, M.; Durieu, E.; Lozach, O.; Carreaux, F.; Meijer, L.; Bazureau, J.-P. Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A. Pharmaceuticals 2021, 14, 1086. https://doi.org/10.3390/ph14111086

AMA Style

Bourahla K, Guihéneuf S, Limanton E, Paquin L, Le Guével R, Charlier T, Rahmouni M, Durieu E, Lozach O, Carreaux F, Meijer L, Bazureau J-P. Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A. Pharmaceuticals. 2021; 14(11):1086. https://doi.org/10.3390/ph14111086

Chicago/Turabian Style

Bourahla, Khadidja, Solène Guihéneuf, Emmanuelle Limanton, Ludovic Paquin, Rémy Le Guével, Thierry Charlier, Mustapha Rahmouni, Emilie Durieu, Olivier Lozach, François Carreaux, Laurent Meijer, and Jean-Pierre Bazureau. 2021. "Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A" Pharmaceuticals 14, no. 11: 1086. https://doi.org/10.3390/ph14111086

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop